ライフサイエンスコーパス: intercellular adhesion molecule

1 evirus A21, an EV with tropism for the human intercellular adhesion molecule 1 (hICAM-1), through ser

2 human melanoma cell line (Lu1205) increased intercellular adhesion molecule 1 (ICAM-1) and E-selecti

3 We find that intercellular adhesion molecule 1 (ICAM-1) and ICAM-2 on

4 the proinflammatory cell adhesion molecules intercellular adhesion molecule 1 (ICAM-1) and vascular

5 e endothelium and in adhesion to immobilized intercellular adhesion molecule 1 (ICAM-1) and vascular

6 ed protein kinases (MAPKs) and expression of intercellular adhesion molecule 1 (ICAM-1) and vascular

7 ction associated antigen 1 (LFA-1) binds the intercellular adhesion molecule 1 (ICAM-1) by its alpha(

8 In this study, the binding affinity of human intercellular adhesion molecule 1 (ICAM-1) chimera and l

9 ezrin/radixin/moesin (ERM) phosphorylation, intercellular adhesion molecule 1 (ICAM-1) clustering, a

10 Infected IL-17R-deficient corneas had low intercellular adhesion molecule 1 (ICAM-1) expression, a

11 Intercellular adhesion molecule 1 (ICAM-1) is a cell-sur

12 The intercellular adhesion molecule 1 (ICAM-1) is induced in

13 to LLV was able to trigger the clustering of intercellular adhesion molecule 1 (ICAM-1) on endothelia

14 ascular cell adhesion molecule (VCAM-1), and intercellular adhesion molecule 1 (ICAM-1) on endothelia

15 scribed as an inflammatory disease, in which intercellular adhesion molecule 1 (ICAM-1) plays a key r

16 re we show that HDL suppresses expression of intercellular adhesion molecule 1 (ICAM-1) through the t

17 shown to bind to several receptors, of which intercellular adhesion molecule 1 (ICAM-1) upregulation

18 Differential expression of VCAM-1 and intercellular adhesion molecule 1 (ICAM-1) was regulated

19 Surprisingly, while intercellular adhesion molecule 1 (ICAM-1) was significa

20 the NF-kappaB pathway instantly upregulates intercellular adhesion molecule 1 (ICAM-1) which binds i

21 This is the case for intercellular adhesion molecule 1 (ICAM-1), a glycoprote

22 ction also increased the cellular content of intercellular adhesion molecule 1 (ICAM-1), a molecule i

23 ow a group of PfEMP1 proteins interacts with intercellular adhesion molecule 1 (ICAM-1), allowing us

24 Surprisingly, the genetic deficiency of intercellular adhesion molecule 1 (ICAM-1), an establish

25 rogenic TGRL increased expression of VCAM-1, intercellular adhesion molecule 1 (ICAM-1), and E-select

26 Leukocyte infiltration, improved levels of intercellular adhesion molecule 1 (ICAM-1), and oxidativ

27 tenuated the over expression of VEGF and the intercellular adhesion molecule 1 (ICAM-1), and reduced

28 gnificant in only 1 replication set included intercellular adhesion molecule 1 (ICAM-1), anti-LG3, am

29 "outside-in" signaling when bound to ligand intercellular adhesion molecule 1 (ICAM-1), but little i

30 vascular cell adhesion molecule 1 (VCAM-1), intercellular adhesion molecule 1 (ICAM-1), E-selectin,

31 d inflammation: coagulation factor III (F3), intercellular adhesion molecule 1 (ICAM-1), interferon g

32 tu-like expression of cadherins, E-selectin, intercellular adhesion molecule 1 (ICAM-1), vascular cel

33 ance of a cellular adhesion protein known as intercellular adhesion molecule 1 (ICAM-1), which helps

34 We examined human effector T lymphocytes on intercellular adhesion molecule 1 (ICAM-1)-coated surfac

35 l host factors impacting protection included intercellular adhesion molecule 1 (ICAM-1)-dependent pol

36 cell morphology alterations, and crawling on intercellular adhesion molecule 1 (ICAM-1)-expressing ce

37 that is enhanced by the binding of LFA-1 to intercellular adhesion molecule 1 (ICAM-1).

38 y TM-thrombin complex and in upregulation of intercellular adhesion molecule 1 (ICAM-1).

39 nt/beta-catenin signaling in AECs attenuated intercellular adhesion molecule 1 (ICAM-1)/vascular cell

40 d proteins HLA-A, HLA-B, and HLA-C antigens; intercellular adhesion molecule 1 (ICAM-1); S100; transc

41 in T cells increased expression of IFNG and intercellular adhesion molecule 1 (ICAM1) and induced T-

42 , unlike amphiregulin and TNFRI, full-length intercellular adhesion molecule 1 (ICAM1) is released fr

43 pression of asparaginyl endopeptidase (AEP), intercellular adhesion molecule 1 (ICAM1), and ras-relat

44 monocyte chemoattractant protein-1 (MCP-1), intercellular adhesion molecule 1 (ICAM1), F4/80, plasmi

45 out mice originated from decreased levels of intercellular adhesion molecule 1 (ICAM1)/vascular cell

46 s, hepatic decompensation, and soluble serum intercellular adhesion molecule 1 (sICAM-1) MFI.

47 t of BMI on inflammatory biomarkers [soluble intercellular adhesion molecule 1 (sICAM-1), high sensit

48 otein (hs-CRP), adiponectin, leptin, soluble intercellular adhesion molecule 1 (sICAM-1), soluble vas

49 han antibodies to transferrin receptor-1 and intercellular adhesion molecule 1 (TfR-1 and ICAM-1).

50 IL-6], IL-8, IL-1alpha, CXCL1, CXCL2, CXCL3, intercellular adhesion molecule 1 [ICAM1]), chemoattract

51 s and to enhanced cell-surface expression of intercellular adhesion molecule 1 and altered expression

52 stained positive for 2 inflammatory markers, intercellular adhesion molecule 1 and interleukin 8.

53 Unexpectedly, other proteins, including intercellular adhesion molecule 1 and moesin, were selec

54 L oxidation and 2) a significant decrease in intercellular adhesion molecule 1 and OLR1 gene expressi

55 Soluble intercellular adhesion molecule 1 and soluble vascular c

56 munoblots were used to measure expression of intercellular adhesion molecule 1 and the inducible form

57 n the luminal surface, such as clustering of intercellular adhesion molecule 1 and vascular cell adhe

58 egulation of the cellular adhesion molecules Intercellular Adhesion Molecule 1 and Vascular Cell Adhe

59 dies against Macrophage-1 antigen (Mac-1) or intercellular adhesion molecule 1 and were reproduced in

60 ion of NF-kappaB, which in turn up-regulated intercellular adhesion molecule 1 as evident from chroma

61 D showed increased endothelial inflammation (intercellular adhesion molecule 1 expression) and increa

62 -1 displayed an attenuated interleukin-6 and intercellular adhesion molecule 1 expression, resulting

63 atter correlated with diastolic function and intercellular adhesion molecule 1 expression.

64 reactive protein, interleukin 6, and soluble intercellular adhesion molecule 1 in plasma.

65 the lymphocyte function-associated antigen 1-intercellular adhesion molecule 1 interaction, reduced T

66 nduced expression of MHC-I, MHC-II, and CD54/intercellular adhesion molecule 1 molecules.

67 but involved class II histocompatibility and intercellular adhesion molecule 1 molecules.

68 cantly increased KC numbers via induction of intercellular adhesion molecule 1 on liver sinusoidal en

69 trast to most other rhinoviruses, which bind intercellular adhesion molecule 1 receptors via a capsid

70 the expression of endothelial E-selectin and intercellular adhesion molecule 1 was decreased by eithe

71 6, tumor necrosis factor alpha, and soluble intercellular adhesion molecule 1 were measured.

72 Focusing on intercellular adhesion molecule 1(ICAM)-1 as a model, we

73 ession for ACE2 and TMPRSS2, and for ICAM-1 (intercellular adhesion molecule 1) (rhinovirus receptor

74 e function-associated antigen 1) for ICAM-1 (intercellular adhesion molecule 1) but significantly low

75 n 6, tumor necrosis factor alpha and soluble intercellular adhesion molecule 1) were unsuitable for p

76 Deficiency of intercellular adhesion molecule 1, a counter-receptor fo

77 The expression of intercellular adhesion molecule 1, an NF-kappaB-dependen

78 phaIIbbeta3 with endothelial alphavbeta3 and intercellular adhesion molecule 1, and (3) a stimulatory

79 4 BCC tumor mRNA markers (CD25, CD3epsilon, intercellular adhesion molecule 1, and CD68) that have b

80 lpha, interleukin (IL)-1beta, IL-6, KC/IL-8, intercellular adhesion molecule 1, and cluster of differ

81 active protein, adiponectin, leptin, soluble intercellular adhesion molecule 1, and E-selectin all fe

82 s showed increased interleukin (IL)-6, IL-8, intercellular adhesion molecule 1, and platelet endothel

83 elated adhesion molecules (e.g., P-selectin, intercellular adhesion molecule 1, and vascular cell adh

84 chemistry of eNOS, endothelin-1, P-selectin, intercellular adhesion molecule 1, and vascular cell adh

85 or necrosis factor alpha, caspase-1 (CASP1), intercellular adhesion molecule 1, IL-10, heme oxygenase

86 anulocyte colony-stimulating factor, soluble intercellular adhesion molecule 1, macrophage migration-

87 selectin, vascular cell adhesion molecule 1, intercellular adhesion molecule 1, platelet endothelial

88 ceptor-2, vascular cell adhesion molecule 1, intercellular adhesion molecule 1, selectins, and integr

89 ld increase in the expression of E-selectin, intercellular adhesion molecule 1, vascular cell adhesio

90 sinophils also showed enhanced expression of intercellular adhesion molecule 1, which depended on dir

91 s also associated with the overexpression of intercellular adhesion molecule 1, which is expressed on

92 ng Raman-active molecules were conjugated to intercellular adhesion molecule 1- (ICAM-1-) specific mo

93 induced pulmonary inflammation, with altered intercellular adhesion molecule 1-dependent slow neutrop

94 gands, vascular cell adhesion molecule 1 and intercellular adhesion molecule 1.

95 orce-dependent kinetics of dissociation from intercellular adhesion molecule 1.

96 ntiation, respectively; the plasma levels of intercellular adhesion molecule 1; and CCR6 expression i

97 th factor beta1 and beta2; thrombospondin 2; intercellular adhesion molecule 1; interleukin 6 [IL-6];

98 rs of endothelial adhesion (sICAM-1 [soluble intercellular adhesion molecule 1] and sVCAM-1 [soluble

99 ICAM (intercellular adhesion molecule)-1 and PFKFB3 were also

100 endothelial cells had higher levels of ICAM (intercellular adhesion molecule)-1 and TF expression fol

101 creased vascular inflammation marker soluble intercellular adhesion molecule-1 (-10%, P < 0.01).

102 r alpha receptor II (B = 0.07, p < .01), and intercellular adhesion molecule-1 (B = 0.04, p < .05) le

103 efined as CD146(+)CD45(-)) exhibit increased intercellular adhesion molecule-1 (CD54) and Fas in resp

104 NOS), nuclear factor-kappa B (NF-kappaB) and intercellular adhesion molecule-1 (ICAM) (P < 0.001, res

105 endothelial adhesion molecules, particularly intercellular adhesion molecule-1 (ICAM-1) and a subsequ

106 ) to circulating pro-inflammatory cytokines, intercellular adhesion molecule-1 (ICAM-1) and acute cor

107 f these cells, concomitant with reduction of intercellular adhesion molecule-1 (ICAM-1) and diminishi

108 contact points for the known HRV receptors, intercellular adhesion molecule-1 (ICAM-1) and low-densi

109 t3 interaction in correlation with increased intercellular adhesion molecule-1 (ICAM-1) and soluble-I

110 lls, we found that GPx-1 deficiency augments intercellular adhesion molecule-1 (ICAM-1) and vascular

111 ular endothelium on which ligands, including intercellular adhesion molecule-1 (ICAM-1) and vascular

112 otential of these cells through reduction of intercellular adhesion molecule-1 (ICAM-1) and vascular

113 udy was to identify mechanisms through which intercellular adhesion molecule-1 (ICAM-1) augments the

114 We have previously shown that intercellular adhesion molecule-1 (ICAM-1) expressed by

115 Intercellular adhesion molecule-1 (ICAM-1) expressing ne

116 tumor necrosis factor-alpha (TNF-alpha) and intercellular adhesion molecule-1 (ICAM-1) in aqueous hu

117 Herein, we describe the overexpression of intercellular adhesion molecule-1 (ICAM-1) in human TNBC

118 ntigen-1 (LFA-1) interaction with its ligand intercellular adhesion molecule-1 (ICAM-1) induces a gen

119 Blocking intercellular adhesion molecule-1 (ICAM-1) inhibited the

120 Intercellular adhesion molecule-1 (ICAM-1) is up-regulat

121 sion and display high spontaneous binding to intercellular adhesion molecule-1 (ICAM-1) ligand under

122 Intercellular adhesion molecule-1 (ICAM-1) mediates the

123 recognition of pMHC and the adhesion ligand intercellular adhesion molecule-1 (ICAM-1) on supported

124 called 3DNA coupled with antibodies against intercellular adhesion molecule-1 (ICAM-1), a glycoprote

125 This study investigated intercellular adhesion molecule-1 (ICAM-1), a membrane p

126 NAME also blocked blast-induced increases in intercellular adhesion molecule-1 (ICAM-1), a molecule t

127 using polymer nanocarriers (NCs) targeted to intercellular adhesion molecule-1 (ICAM-1), an endotheli

128 PfEMP1 and human endothelial proteins CD36, intercellular adhesion molecule-1 (ICAM-1), and endothel

129 tor inhibitor-1, soluble E-selectin, soluble intercellular adhesion molecule-1 (ICAM-1), and soluble

130 scular cell adhesion molecule-1 (VCAM-1) and intercellular adhesion molecule-1 (ICAM-1), endothelial

131 elial migration mediated by a combination of intercellular adhesion molecule-1 (ICAM-1), vascular adh

132 t endothelial adhesion molecule-1 (PECAM-1), intercellular adhesion molecule-1 (ICAM-1), vascular adh

133 pha by restraining the induced expression of intercellular adhesion molecule-1 (ICAM-1), vascular cel

134 sation requires selectin-mediated tethering, intercellular adhesion molecule-1 (ICAM-1)-dependent fir

135 ated neutrophils, microglia/macrophages, and intercellular adhesion molecule-1 (ICAM-1)-positive bloo

136 dhesion molecules in the vasculature such as intercellular adhesion molecule-1 (ICAM-1).

137 otein that interacts with the host receptor, intercellular adhesion molecule-1 (ICAM-1).

138 ) in a low affinity state to slow rolling on intercellular adhesion molecule-1 (ICAM-1).

139 ression was notable in blood vessels, as was intercellular adhesion molecule-1 (ICAM-1).

140 immunohistochemically for the expression of intercellular adhesion molecule-1 (ICAM-1).

141 of the endothelial mechanosensitive receptor intercellular adhesion molecule-1 (ICAM-1).

142 protein (LDL) cholesterol, triglyceride, and intercellular adhesion molecule-1 (ICAM-1).

143 kers human leukocyte antigen-DR (HLA-DR) and intercellular adhesion molecule-1 (ICAM-1).

144 urface proteins, including CD69, L-selectin, intercellular adhesion molecule-1 (ICAM-1, CD54), CD44,

145 ster of differentiation 8a (Cd8a), Cd14, and intercellular adhesion molecule-1 (Icam1) by about two-f

146 in mice, these progenitor cells give rise to intercellular adhesion molecule-1 (ICAM1)/CD54-expressin

147 ine to 2-month follow-up in concentration of intercellular adhesion molecule-1 (P < .001), interleuki

148 the prospective association between soluble intercellular adhesion molecule-1 (sICAM-1) and cancer r

149 dence of proliferative DR (PDR), and soluble intercellular adhesion molecule-1 (sICAM-1) and TNF-alph

150 active protein (CRP), serum amyloid A (SAA), intercellular adhesion molecule-1 (sICAM-1) and vascular

151 e measured levels of UA and soluble forms of intercellular adhesion molecule-1 (sICAM-1), vascular ce

152 Soluble intercellular adhesion molecule-1 (sICAM1) was measured

153 generate polyplexes carrying siRNA targeting intercellular adhesion molecule-1 (siICAM-1).

154 crosis Factor receptor II [sTNFRII], soluble Intercellular Adhesion Molecule-1 [sICAM-1]), angiogenic

155 Clinical risk factors, soluble intercellular adhesion molecule-1 and endocan (both form

156 [sRAGE]) and endothelial biomarkers (soluble intercellular adhesion molecule-1 and endocan [full-leng

157 n, including the metastasis-related proteins intercellular adhesion molecule-1 and urokinase-type pla

158 The lymphatic endothelium expresses intercellular adhesion molecule-1 and vascular adhesion

159 We also measured the expression of intercellular adhesion molecule-1 and vascular cell adhe

160 A1 exon skipping mutations had higher plasma intercellular adhesion molecule-1 and vascular cell adhe

161 , CCL5, and CCL20 and the adhesion molecules intercellular adhesion molecule-1 and vascular cell adhe

162 re, CB2R agonists decreased the induction of intercellular adhesion molecule-1 and vascular cell adhe

163 alpha receptor II) and endothelial function (intercellular adhesion molecule-1 and vascular cell adhe

164 ference studies identified interleukin-6 and intercellular adhesion molecule-1 as key NF-kappaB targe

165 ssays and monocyte chemotactic protein-1 and intercellular adhesion molecule-1 as model genes.

166 We hypothesized that the expression of intercellular adhesion molecule-1 even in vessels with h

167 ced tumor necrosis factor (TNF)alpha-induced intercellular adhesion molecule-1 expression and attenua

168 eling-positive cells, TNF-alpha release, and intercellular adhesion molecule-1 expression compared wi

169 ase products and IL-10 and reduced CD11b and intercellular adhesion molecule-1 expression on neutroph

170 leased platelet miR-320b on endothelial cell intercellular adhesion molecule-1 expression was shown.

171 reased vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression, and neutro

172 Removal of P-Rex1 significantly reduced intercellular adhesion molecule-1 expression, polymorpho

173 anism and induced an increase in endothelial intercellular adhesion molecule-1 expression, production

174 helial vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression, reduced in

175 HUVEC intercellular adhesion molecule-1 expression, stiffness,

176 treatment failed to inhibit TNFalpha-induced intercellular adhesion molecule-1 expression, treatment

177 he effect of adiponectin on TNFalpha-induced intercellular adhesion molecule-1 expression.

178 on, and endothelial activation, monitored by intercellular adhesion molecule-1 expression.

179 nduced vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression.

180 ges have been assumed to mediate adhesion to intercellular adhesion molecule-1 for T-cell conjugation

181 ses in vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 mRNA expression in the

182 Blocking intercellular adhesion molecule-1 prevents cellular egre

183 es produced greater levels of chemokines and intercellular adhesion molecule-1 that are associated wi

184 Binding of intercellular adhesion molecule-1 to the beta2-integrin

185 spleen tyrosine kinase and cell adhesion to intercellular adhesion molecule-1 under dynamic flow.

186 n-8, monocyte chemoattactrant protein-1, and intercellular adhesion molecule-1 were analyzed after tr

187 e vascular cell adhesion molecule-1, soluble intercellular adhesion molecule-1) and immune (soluble t

188 uced pulmonary adhesion molecule expression (intercellular adhesion molecule-1) and tissue infiltrati

189 MC releasate elevated ICAM-1 (intercellular adhesion molecule-1) expression on HUVEC (

190 activator [tPA]) and endothelial activation (intercellular adhesion molecule-1) in serial biopsies ob

191 ascular cell adhesion molecule-1 and soluble intercellular adhesion molecule-1) were measured.

192 ons of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1, albeit less efficient

193 ssion of vascular endothelial growth factor, intercellular adhesion molecule-1, and tumor necrosis fa

194 unds of RW decreased serum concentrations of intercellular adhesion molecule-1, E-selectin, and IL-6

195 expression of NF-kappaB target genes VCAM-1, intercellular adhesion molecule-1, E-selectin, and tissu

196 rial loads were associated with higher serum intercellular adhesion molecule-1, E-selectin, and vascu

197 selectin, vascular cell adhesion molecule-1, intercellular adhesion molecule-1, fibrinogen-like prote

198 Soluble intercellular adhesion molecule-1, IFN-lambda1, and eosi

199 nd inflammatory markers [C-reactive protein, intercellular adhesion molecule-1, interleukin-6, and tu

200 high-sensitivity C-reactive protein, soluble intercellular adhesion molecule-1, leptin, hemoglobin A(

201 Model 3 identified a set of 6 biomarkers (intercellular adhesion molecule-1, matrix metalloprotein

202 iomarkers strongly associated with death/MI: intercellular adhesion molecule-1, matrix metalloprotein

203 osis protein-2, cyclin D1, cyclooxygenase-2, intercellular adhesion molecule-1, matrix metalloprotein

204 enofibrate also attenuated overexpression of intercellular adhesion molecule-1, monocyte chemoattract

205 ession of vascular cell adhesion molecule-1, intercellular adhesion molecule-1, monocyte chemoattract

206 ut reduced expression or secretion of T-bet, intercellular adhesion molecule-1, nucleotide-binding ol

207 th changes in von Willebrand factor, soluble intercellular adhesion molecule-1, soluble E-Selectin, P

208 levels of C-reactive protein, interleukin-6, intercellular adhesion molecule-1, soluble tumor necrosi

209 , angiopoietin-1 and angiopoietin-2, soluble intercellular adhesion molecule-1, soluble vascular cell

210 sitivity C-reactive protein, fibrinogen, and intercellular adhesion molecule-1, suggested that GlycA

211 or necrosis factor-alpha, interleukin-6, and intercellular adhesion molecule-1, than iron-overloaded

212 In human lung tissues, intercellular adhesion molecule-1, vascular cell adhesio

213 e chemotactic protein-1, C-reactive protein, intercellular adhesion molecule-1, vascular cell adhesio

214 (tumor necrosis factor-alpha, interleukin-6, intercellular adhesion molecule-1, vascular cell adhesio

215 gamma), endothelial cell adhesion molecules (intercellular adhesion molecule-1, vascular cell adhesio

216 ay and expression of cell adhesion molecules intercellular adhesion molecule-1, vascular cell adhesio

217 ecreted levels of the proangiogenic proteins intercellular adhesion molecule-1, vascular cell adhesio

218 microscopy and contrast-enhanced ultrasound, intercellular adhesion molecule-1-targeted and rhodamine

219 Intercellular adhesion molecule-1-targeted and rhodamine

220 s were translatable in vivo, confirming that intercellular adhesion molecule-1-targeted and rhodamine

221 complement fragments iC3b and C3d but not to intercellular adhesion molecule-1.

222 ectin, retinol-binding protein 4) or soluble intercellular adhesion molecule-1.

223 phages adhere to the beta(2) integrin ligand intercellular adhesion molecule-1.

224 senting cells was predominantly dependent on intercellular adhesion molecule-1.

225 geal fibroblasts after LIGHT stimulation via intercellular adhesion molecule-1.

226 radation, and decreases expression levels of intercellular adhesion molecule-1.

227 ls of plasma endothelial biomarkers (soluble intercellular adhesion molecule-1: OR, 1.58; 95% CI, 1.2

228 M [vascular cell adhesion molecule-1], ICAM [intercellular adhesion molecule-1], and MCP1 [monocyte c

229 huTreg, or their respective porcine ligands intercellular adhesion molecule 2 (CD102) and vascular c

230 sured on choroidal-scleral flat mounts using intercellular adhesion molecule 2 immunofluorescence sta

231 riven by an endothelial-specific promoter of intercellular adhesion molecule 2.

232 ard this goal, we recently demonstrated that intercellular adhesion molecule-2 (ICAM-2) converted neu

233 and beta1, and their counterligands, such as intercellular adhesion molecule-2 and P-selectin, in bre

234 on Willebrand factor [vWF], VE-cadherin, and intercellular adhesion molecule-2), but not all (eg, VEG

235 Serum levels of E-selectin, intercellular adhesion molecule 3 matrix metalloproteina

236 eting the C-type lectin receptor DC-specific intercellular adhesion molecule 3-grabbing nonintegrin (

237 and 2, dectin 1, and dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin i

238 annose receptor- and dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin-m

239 engulfed by mucosal dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin-p

240 better interaction with DC-SIGN [DC-specific intercellular adhesion molecule-3 (ICAM-3)-grabbing noni

241 the C-type lectins, dendritic cell-specific intercellular adhesion molecule-3 grabbing non-integrin

242 r binding toward the dendritic cell-specific intercellular adhesion molecule-3 grabbing non-integrin

243 ans cells (LCs), and dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin

244 or downregulation of dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin

245 face lectin DC-SIGN (dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin)

246 Dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (

247 R, efficiently bound dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (

248 the C-type lectin receptor (CLR) DC-specific intercellular adhesion molecule-3-grabbing nonintegrin (

249 recognition receptor dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (

250 was not mediated by dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (

251 r receptors, such as dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (

252 s able to bind human dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (

253 receptors, including dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (

254 pressing the lectins dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (

255 the lectin receptor dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (

256 We used dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin a

257 DC-SIGN (dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin)

258 ding molecules CCR5, dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin,

259 CD3, CCR5, Langerin, dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin,

260 d F(ab')2 fragments of IVIg with DC-specific intercellular adhesion molecule-3-grabbing nonintegrin.

261 repeats and discoidin I-like domains 3, and intercellular adhesion molecule 4; the first three have

262 ecule (BCAM/Lu) and ECM laminin, and between intercellular adhesion molecule-4 (ICAM-4) and endotheli

263 RBCs to endothelial cells is mediated by the intercellular adhesion molecule-4 (ICAM-4), which appear

264 rocyte adhesion receptor Landsteiner-Wiener (intercellular adhesion molecule-4).

265 Here we identify neuron-specific intercellular adhesion molecule 5 (ICAM-5/telencephalin)

266 al fibrillary acidic protein (p = 0.001) and intercellular adhesion molecule-5 (p = 0.001).

267 The telencephalon-associated intercellular adhesion molecule-5 (telencephalin; ICAM-5

268 f) ligand 2, neuron-specific enolase, S100b, intercellular adhesion molecule-5, and brain-derived neu

269 e (VCAM); 5) interleukin (IL)-6; 6) IL-8; 7) intercellular adhesion molecule; and 8) IL-10.

270 -1, Bax and caspase-3, protein expression of intercellular adhesion molecule as well as the number of

271 Soluble endothelial selectin and soluble intercellular adhesion molecule concentrations decreased

272 that AP-1 regulates the localization of the intercellular adhesion molecule E-cadherin and that loss

273 duced pulmonary interleukin-6 transcription, intercellular adhesion molecule expression, neutrophil i

274 th complex I inhibition, NFKB activation and intercellular adhesion molecule expression.

275 NFAT-independent adhesion of T cells to the intercellular adhesion molecule ICAM-1, with little effe

276 t but is essential for efficient adhesion to intercellular adhesion molecule (ICAM) 1 and vascular ce

277 retained locally through constitutive LFA-1-intercellular adhesion molecule (ICAM) 1 interactions.

278 cular cell adhesion molecule (VCAM), but not intercellular adhesion molecule (ICAM), suggesting they

279 E-selectin and intercellular adhesion molecule (ICAM)-1 are biomarkers

280 exhibiting a 70 and 50% increase in retinal intercellular adhesion molecule (ICAM)-1 expression and

281 Intercellular adhesion molecule (ICAM)-1 functions to en

282 ctivity of platelets taken from mice lacking intercellular adhesion molecule (ICAM)-1 identified a ma

283 nied by significant reduction of circulating intercellular adhesion molecule (ICAM)-1 was observed.

284 ng loops in vascular cell adhesion molecule, intercellular adhesion molecule (ICAM)-1, ICAM-2, ICAM-3

285 In the validation cohort concentrations of intercellular adhesion molecule (ICAM)-1, IL-8, and vasc

286 Antibody blockade of intercellular adhesion molecule (ICAM)-1, vascular cell

287 f other genes such as interleukin (IL)-8 and intercellular adhesion molecule (ICAM)-1.

288 ascular cell adhesion molecule (VCAM)-1, and intercellular adhesion molecule (ICAM)-1.

289 found on lymphocytes, and its cognate ligand intercellular adhesion molecule (ICAM)-1.

290 al region includes selected residues from an intercellular adhesion molecule (ICAM)-like motif shared

291 E(-)H(+) beta2 integrins bind intercellular adhesion molecules (ICAMs) in cis, which i

292 igen-1 (LFA-1; integrin alpha(L)beta(2)) for intercellular adhesion molecules (ICAMs) on endothelia o

293 rations in the jugular bulb, whereas soluble intercellular adhesion molecule increased significantly

294 ve activities involved CD40, CD80, CD86, and intercellular adhesion molecule interactions and require

295 ndent decrease in cell surface levels of the intercellular adhesion molecule PECAM-1 (CD31) when exam

296 Elevated serum levels of soluble-intercellular adhesion molecule, soluble-vascular cell a

297 spine apparatus, and telencephalin (TLCN, or intercellular adhesion molecule type 5), a protein assoc

298 h factor, von Willebrand factor, E-selectin, intercellular adhesion molecule, vascular cell adhesion

299 e kinase, von Willebrand factor, E-selectin, intercellular adhesion molecule, vascular cell adhesion

300 complex), and the adhesion molecule soluble intercellular adhesion molecule were measured.